Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL vs TRAVOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPROSTADIL vs TRAVOPROST: Safety Overview

Metric ALPROSTADIL TRAVOPROST
Total FAERS Reports 2,800 6,455
Deaths Reported 60 145
Death Rate 2.1% 2.2%
Hospitalizations 210 164
Average Patient Age 62.5 yrs 71.6 yrs
% Female Patients 4.9% 63.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 13, 2023
Manufacturer ENDO USA, Inc. Sagent Pharmaceuticals
Route INTRACAVERNOUS OPHTHALMIC
Marketing Status Prescription Discontinued